Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Classement en actions #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Prix de l'action
$29.82
Dernière synchronisation: 2023-04-11
Capitalisation boursière
$223.68M
Changement (1 jour)
1.21%
Changement (1 an)
0.00%
Pays
CA
Échange Neovasc Inc. (NVCN)

Catégorie

Ratio P/S pour Neovasc Inc. (NVCN)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Neovasc Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Neovasc Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
4.10 -
US
4.80 -
US
2.78 -
IE
3.42 -
US
8.02 -
US